Human immunodeficiency virus antigen
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 29, 1989
Grant Date -
N/A
app pub date -
Feb 2, 1987
filing date -
Feb 2, 1987
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A recombinant peptide displaying the antigenicity of Human Immunodeficiency Virus (HIV) viral antigens is disclosed. The peptide comprises an antigenic segment having about 150 to about 400 amino acids corresponding to at least about 30 amino acids of the C-terminal of the gp120 domain and at least about 120 amino acids of the N-terminal of the gp41 domain.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully